Navicare Biotech Co., Ltd. (TPEX:8472)

Navicare Biotech Revenue

Navicare Biotech had revenue of 125.91M TWD in the quarter ending June 30, 2026, a decrease of -10.74%. This brings the company's revenue in the last twelve months to 505.82M, up 29.26% year-over-year. In the year 2025, Navicare Biotech had annual revenue of 478.07M with 41.85% growth.

• Revenue (ttm): 505.82M
• Revenue Growth: +29.26%
• P/S Ratio: 2.61
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.32B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	478.07M	141.04M	41.85%
Dec 31, 2024	337.03M	-51.47M	-13.25%
Dec 31, 2023	388.50M	56.95M	17.18%
Dec 31, 2022	331.55M	26.27M	8.60%
Dec 31, 2021	305.28M	-109.14M	-26.33%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 8, 2026

Data Sources Report a data error